{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:46:41Z","timestamp":1767844001394,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"DOI":"10.7759\/cureus.66308","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:48:28Z","timestamp":1722966508000},"source":"Crossref","is-referenced-by-count":1,"title":["Single-Dose Calcium Channel Blocker Toxicity in a Patient With Severe Liver Disease"],"prefix":"10.7759","author":[{"given":"Shweta","family":"Lodha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Loriaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L","family":"Faulkner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathyrn","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreyansh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S374887","article-title":"Calcium channel blocker toxicity: a practical approach","volume":"15","author":"Alshaya OA","year":"2022","unstructured":"Alshaya OA, Alhamed A, Althewaibi S, et al.. Calcium channel blocker toxicity: a practical approach. J Multidiscip Healthc. 2022, 15:1851-62. 10.2147\/JMDH.S374887","journal-title":"J Multidiscip Healthc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05417-z","article-title":"Prophylactic nimodipine treatment for hearing preservation after vestibular schwannoma surgery: study protocol of a randomized multi-center phase III trial-AkniPro 2","volume":"22","author":"Scheller C","year":"2021","unstructured":"Scheller C, Strauss C, Leisz S, et al.. Prophylactic nimodipine treatment for hearing preservation after vestibular schwannoma surgery: study protocol of a randomized multi-center phase III trial-AkniPro 2. Trials. 2021, 22:475. 10.1186\/s13063-021-05417-z","journal-title":"Trials"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.7087","article-title":"Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension","volume":"180","author":"Savage RD","year":"2020","unstructured":"Savage RD, Visentin JD, Bronskill SE, et al.. Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension. JAMA Intern Med. 2020, 180:643-51. 10.1001\/jamainternmed.2019.7087","journal-title":"JAMA Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2018.1533727","article-title":"2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report","volume":"56","author":"Gummin DD","year":"2018","unstructured":"Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol (Phila). 2018, 56:1213-415. 10.1080\/15563650.2018.1533727","journal-title":"Clin Toxicol (Phila)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2011.586337","article-title":"Cytochrome P450-mediated cardiovascular drug interactions","volume":"7","author":"Scheen AJ","year":"2011","unstructured":"Scheen AJ. Cytochrome P450-mediated cardiovascular drug interactions. Expert Opin Drug Metab Toxicol. 2011, 7:1065-82. 10.1517\/17425255.2011.586337","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/1389200043489054","article-title":"The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes","volume":"5","author":"Elbekai RH","year":"2004","unstructured":"Elbekai RH, Korashy HM, El-Kadi AO. The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes. Curr Drug Metab. 2004, 5:157-67. 10.2174\/1389200043489054","journal-title":"Curr Drug Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i9.1959","article-title":"Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes","volume":"9","author":"Yang LQ","year":"2003","unstructured":"Yang LQ, Yu WF, Cao YF, Gong B, Chang Q, Yang GS. Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol. 2003, 9:1959-62. 10.3748\/wjg.v9.i9.1959","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0229","article-title":"Aprepitant and fosaprepitant: a 10-year review of efficacy and safety","volume":"20","author":"Aapro M","year":"2015","unstructured":"Aapro M, Carides A, Rapoport BL, Schmoll HJ, Zhang L, Warr D. Aprepitant and fosaprepitant: a 10-year review of efficacy and safety. Oncologist. 2015, 20:450-8. 10.1634\/theoncologist.2014-0229","journal-title":"Oncologist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000436","article-title":"2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association","volume":"54","author":"Hoh BL","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, et al.. 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2023, 54:e314-70. 10.1161\/STR.0000000000000436","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3171\/2016.8.JNS16626","article-title":"Prophylactic nimodipine treatment and improvement in hearing outcome after vestibular schwannoma surgery: a combined analysis of a randomized, multicenter, phase III trial and its pilot study","volume":"127","author":"Scheller C","year":"2017","unstructured":"Scheller C, Wienke A, Tatagiba M, et al.. Prophylactic nimodipine treatment and improvement in hearing outcome after vestibular schwannoma surgery: a combined analysis of a randomized, multicenter, phase III trial and its pilot study. J Neurosurg. 2017, 127:1376-83. 10.3171\/2016.8.JNS16626","journal-title":"J Neurosurg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms151018453","article-title":"Investigation of the neuroprotective impact of nimodipine on Neuro2a cells by means of a surgery-like stress model","volume":"15","author":"Herzfeld E","year":"2014","unstructured":"Herzfeld E, Strauss C, Simmermacher S, Bork K, Horstkorte R, Dehghani F, Scheller C. Investigation of the neuroprotective impact of nimodipine on Neuro2a cells by means of a surgery-like stress model. Int J Mol Sci. 2014, 15:18453-65. 10.3390\/ijms151018453","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18050964","article-title":"Nimodipine but not nifedipine promotes expression of fatty acid 2-hydroxylase in a surgical stress model based on Neuro2a cells","volume":"18","author":"Herzfeld E","year":"2017","unstructured":"Herzfeld E, Speh L, Strauss C, Scheller C. Nimodipine but not nifedipine promotes expression of fatty acid 2-hydroxylase in a surgical stress model based on Neuro2a cells. Int J Mol Sci. 2017, 18:964. 10.3390\/ijms18050964","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules20011003","article-title":"Neuroprotective and neuroregenerative effects of nimodipine in a model system of neuronal differentiation and neurite outgrowth","volume":"20","author":"Bork K","year":"2015","unstructured":"Bork K, Wurm F, Haller H, Strauss C, Scheller C, Gnanapragassam VS, Horstkorte R. Neuroprotective and neuroregenerative effects of nimodipine in a model system of neuronal differentiation and neurite outgrowth. Molecules. 2015, 20:1003-13. 10.3390\/molecules20011003","journal-title":"Molecules"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-020-00322-3","article-title":"Nimodipine pharmacokinetic variability in various patient populations","volume":"20","author":"Mahmoud SH","year":"2020","unstructured":"Mahmoud SH, Ji X, Isse FA. Nimodipine pharmacokinetic variability in various patient populations. Drugs R D. 2020, 20:307-18. 10.1007\/s40268-020-00322-3","journal-title":"Drugs R D"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12763","article-title":"Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies","volume":"81","author":"Graudins A","year":"2016","unstructured":"Graudins A, Lee HM, Druda D. Calcium channel antagonist and beta-blocker overdose: antidotes and adjunct therapies. Br J Clin Pharmacol. 2016, 81:453-61. 10.1111\/bcp.12763","journal-title":"Br J Clin Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200423040-00003","article-title":"Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity","volume":"23","author":"DeWitt CR","year":"2004","unstructured":"DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004, 23:223-38. 10.2165\/00139709-200423040-00003","journal-title":"Toxicol Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2014.965827","article-title":"Treatment for calcium channel blocker poisoning: a systematic review","volume":"52","author":"St-Onge M","year":"2014","unstructured":"St-Onge M, Dub\u00e9 PA, Gosselin S, et al.. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol (Phila). 2014, 52:926-44. 10.3109\/15563650.2014.965827","journal-title":"Clin Toxicol (Phila)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000278916.04569.23","article-title":"Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil","volume":"35","author":"Levine M","year":"2007","unstructured":"Levine M, Boyer EW, Pozner CN, Geib AJ, Thomsen T, Mick N, Thomas SH. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007, 35:2071-5. 10.1097\/01.ccm.0000278916.04569.23","journal-title":"Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.01.03","article-title":"The potential detrimental effects of calcium channel blockers' overdose and current available management","volume":"6","author":"Agarwal MA","year":"2018","unstructured":"Agarwal MA, Flatt D, Khouzam RN. The potential detrimental effects of calcium channel blockers' overdose and current available management. Ann Transl Med. 2018, 6:16. 10.21037\/atm.2018.01.03","journal-title":"Ann Transl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/JNN.0000000000000464","article-title":"Pharmacogenomics of cytochrome P450 of nimodipine metabolism after aneurysmal subarachnoid hemorrhage","volume":"51","author":"Peacock SH","year":"2019","unstructured":"Peacock SH, James C, Turnbull MT, Cowart JB, Reid JM, Freeman WD. Pharmacogenomics of cytochrome P450 of nimodipine metabolism after aneurysmal subarachnoid hemorrhage. J Neurosci Nurs. 2019, 51:238-42. 10.1097\/JNN.0000000000000464","journal-title":"J Neurosci Nurs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275678-single-dose-calcium-channel-blocker-toxicity-in-a-patient-with-severe-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:48:31Z","timestamp":1722966511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275678-single-dose-calcium-channel-blocker-toxicity-in-a-patient-with-severe-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.66308","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}